32403-69-3

Usage

Uses

Used in Agricultural Industry:
2-(2,4-DINITRO PHENYLTHIO) ACETIC ACID is used as a herbicide for controlling the growth of unwanted plants in agricultural settings. It functions by inhibiting the formation of ethylene, a plant hormone that promotes ripening and aging, thereby helping to maintain the freshness and quality of crops.
2-(2,4-DINITRO PHENYLTHIO) ACETIC ACID is also used as a plant growth regulator to manage the ripening process in fruits and vegetables. By controlling the ethylene levels, DNPTA can extend the shelf life of produce, reducing spoilage and waste.
Used in Research and Development:
In the field of agricultural research and development, 2-(2,4-DINITRO PHENYLTHIO) ACETIC ACID is utilized for studying the effects of ethylene on plant growth and development. It aids in the development of new strategies and products to improve crop yield, quality, and resistance to diseases and pests.

InChI:InChI=1/C8H6N2O6S/c11-8(12)4-17-7-2-1-5(9(13)14)3-6(7)10(15)16/h1-3H,4H2,(H,11,12)

Upstream product

• 68-11-1 mercaptoacetic acid 
• 97-00-7 1-chloro-2,4-dinitro-benzene 
• 1373156-67-2 2-(benzo[d]thiazol-2-yl)phenyl 2,4-dinitrobenzenesulfonate 
• 70-34-8 2,4-Dinitrofluorobenzene 
• 2218-96-4 2,4-dinitrothiophenol 
• 79-11-8 chloroacetic acid 
• 2217-55-2 bis(2,4-dinitrophenyl) disulphide 

Downstream Products

• 459187-93-0 (2,4-dinitro-benzenesulfonyl)-acetic acid 
• 21762-78-7 6-amino-2H-1,4-benzothiazin-3(4H)-one 
• 93801-70-8 2,4-dinitrophenylthioglycolic acid N-hydroxy succinimide ester 
• 105892-21-5 (2,4-Dinitro-phenylsulfanyl)-acetic acid; compound with 2-(2-hydroxy-ethylamino)-ethanol 
• 93801-71-9 N-Benzyl-2-(2,4-dinitro-phenylsulfanyl)-acetamide 
• 93801-67-3 N-{(2R,3S,5R,6R)-5-Amino-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-2-hydroxy-cyclohexyloxy]-3-hydroxy-tetrahydro-pyran-2-ylmethyl}-2-(2,4-dinitro-phenylsulfanyl)-acetamide 
• 835-57-4 methyl 2,4-dinitrophenyl sulfone 
• 105892-20-4 (2,4-Dinitro-phenylsulfanyl)-acetic acid; compound with 2-amino-ethanol 
• 105892-22-6 Tris-(2-hydroxyethyl)ammonium 2,4-dinitrophenylthioacetate 
• 21762-74-3 6-nitro-3,4-dihydro-3-oxo-2H(1,4)benzothiazine 
• 2942-07-6 5-nitrobenzothiazole 
• 4871-30-1 methyl (2,4-dinitrophenylsulphanyl)ethanoate 

Relevant academic research and scientific papers

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

A benzothiazole-based fluorescent probe for thiol bioimaging

This study reports a benzothiazole-based fluorescent probe with simple structure for thiols. This probe exhibited high on/off signal ratios and good selectivity toward thiols over other analytes, and was successfully applied to the imaging of thiols in living cells.

COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

Synthesis of alkanolammonium arylthio(sulfonyl)alkanoates and their use for concentration of copper and copper-molybdenum ores

Alkanolammonium arylthio(sulfonyl)acetates are prepared, and their flotation properties in concentration of copper and copper-molybdenum ores studied.